Edition:
United States

Keryx Biopharmaceuticals Inc (KERX.OQ)

KERX.OQ on NASDAQ Stock Exchange Capital Market

5.00USD
2:50pm EST
Change (% chg)

$0.09 (+1.83%)
Prev Close
$4.91
Open
$4.90
Day's High
$5.07
Day's Low
$4.90
Volume
208,521
Avg. Vol
436,539
52-wk High
$8.37
52-wk Low
$4.02

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 18.68 -0.255
Sep '17 15.00 -0.197
Jun '17 15.14 -0.768
Mar '17 11.82 -0.215
FY 2016 Dec '16 9.53 -0.319
Sep '16 6.34 -0.394
Jun '16 9.29 -0.422
Mar '16 6.82 -0.388
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 5 21.98 24.33 19.00 27.98
Quarter Ending Jun-18 5 25.24 26.54 23.00 34.19
Year Ending Dec-18 7 109.28 114.31 100.00 124.09
Year Ending Dec-19 8 170.59 239.70 128.70 215.86
Earnings (per share)
Quarter Ending Mar-18 8 -0.18 -0.14 -0.25 0.03
Quarter Ending Jun-18 8 -0.16 -0.13 -0.22 0.06
Year Ending Dec-18 6 -0.60 -0.47 -0.81 -0.21
Year Ending Dec-19 7 -0.20 -0.03 -0.32 0.22
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 187.16 35.64
P/E High - Last 5 Yrs. -- 283.01 46.80
P/E Low - Last 5 Yrs. -- 92.63 24.18
Beta 2.57 0.81 0.81
Price to Sales (TTM) 9.65 144.25 8.67
Price to Book (MRQ) -- 19.79 5.21
Price to Tangible Book (MRQ) -- 26.40 6.35
Price to Cash Flow (TTM) -- 124.99 26.03
% Owned Institutions 66.65 11.86 2.27

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.51
Dividend Yield - 5 Year Avg -- 0.20 2.01
Dividend 5 Year Growth Rate -- 1.92 5.24
Payout Ratio(TTM) -- 8.43 44.74

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 95.97 19.88 9.21
Sales (TTM) vs TTM 1 Yr. Ago 89.60 61.01 7.55
Sales - 5 Yr. Growth Rate -- 32.71 10.21
EPS (MRQ) vs Qtr. 1 Yr. Ago 19.93 -97.85 16.86
EPS (TTM) vs TTM 1 Yr. Ago 5.66 -- --
EPS - 5 Yr. Growth Rate -- 46.54 11.51
Capital Spending - 5 Yr. Growth Rate -- 42.29 14.77

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.42
Current Ratio (MRQ) -- 5.73 3.38
LT Debt to Equity (MRQ) -- 16.72 12.01
Total Debt to Equity (MRQ) -- 18.87 15.38
Interest Coverage (TTM) -30.54 -164.25 39.15

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 58.72 51.19 54.84
Gross Margin - 5 Yr. Avg. -- 55.55 52.61
EBITD Margin (TTM) -166.56 -- --
EBITD - 5 Yr. Avg -396.26 -566.09 9.77
Operating Margin (TTM) -167.69 -598.23 2.53
Operating Margin - 5 Yr. Avg. -397.84 -587.15 5.00
Pre-Tax Margin (TTM) -269.91 -568.90 3.34
Pre-Tax Margin - 5 Yr. Avg. -487.63 -595.33 5.26
Net Profit Margin (TTM) -269.52 -564.05 -0.18
Net Profit Margin - 5 Yr. Avg. -488.15 -599.22 1.54
Effective Tax Rate (TTM) -- 0.16 22.12
Effective Tax Rate - 5 Yr. Avg. -- 17.90 24.22

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,686,315 822,216,427
Net Income/Employee (TTM) -- -650,139 96,151,835
Receivable Turnover (TTM) -- 14.03 5.40
Inventory Turnover (TTM) -- 2.43 3.51
Asset Turnover (TTM) -- 0.39 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -1.09 10.70
Return on Assets - 5 Yr. Avg. -- -0.33 12.00
Return on Investment (TTM) -- -0.71 13.57
Return on Investment - 5 Yr. Avg. -- 2.30 15.72
Return on Equity (TTM) -- -3.52 15.19
Return on Equity - 5 Yr. Avg. -- -1.79 16.94
  1 Year 3 Year 5 Year
Sales % 89.60 77.60 --
EPS (TTM) % 6.22 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Keryx Biopharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 66.69%
# of Holders: 184
Total Shares Held: 79,508,831
3 Mo. Net Change: -400,035
# New Positions: 25
# Closed Positions: 27
# Increased Positions: 77
# Reduced Positions: 68
# Net Buyers: 9
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.